Tradestie Institutional Equity Comparison Engine

CELU vs GPCR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GPCR Overall Edge

GPCR Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Structure Therapeutics Inc. American Depositary Shares (GPCR) driven by superior Growth & Margin, Options & Structure while CELU counters with relative strength in Momentum & Technical. Fundamentally, CELU trades at N/M Forward P/E with -254.0% operating margin (-5.3% YoY revenue) versus GPCR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CELU sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro) against GPCR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CELU N/M vs GPCR N/M Fwd P/E
Growth & Margin Winner GPCR
Op Margin -254.0% vs 0.0% ยท YoY -5.3% vs +0.0%
Momentum & Technical Winner CELU
1Y -72.6% vs -55.8% ยท 52W Pos 2% vs 0%
Options & Structure Winner GPCR
BREAKDOWN (50th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
CELU NASDAQ
Celularity Inc. Class A Common Stock
Pharmaceutical Preparations
$0.46
-1.05% 1D
Market Cap $15.2M
1M Return -55.9%
1Y Return -72.6%
Forward P/E N/M
Unified AI Score
42.9 / 100 HOLD
Tech 25.0 Fund 48.0 Flow 67.0 Mom 55.0
GPCR NASDAQ
Structure Therapeutics Inc. American Depositary Shares
Pharmaceutical Preparations
$16.13
-5.78% 1D
Market Cap $1.2B
1M Return -26.45%
1Y Return -55.82%
Forward P/E N/M
Unified AI Score
40.9 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CELU -72.6% GPCR -55.82% Spread: +16.78 pp (GPCR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CELU TTM Op. Margin: -254.0% GPCR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CELU vs GPCR. Trailing 12-month operating profitability (CELU -254.0% vs GPCR 0.0%) and valuation multiples (CELU N/M vs GPCR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CELU (2) vs GPCR (6)
Institutional Metric CELU GPCR Criterion Row Winner
Market Capitalization Scale $15.2M $1.2B Larger Scale GPCR
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -5.3% +0.0% Higher Growth GPCR
Operating Margin (TTM) Profitability -254.0% 0.0% Higher Margin GPCR
Net Profit Margin Profitability -245.7% 0.0% Higher Margin GPCR
Return on Equity (ROE) Capital Efficiency -6367.2% -29.5% Higher ROE GPCR
52-Week Range Position Momentum 2% ($0โ€“$3) 0% ($16โ€“$95) Stronger Trend CELU
Beta / 30D Volatility Risk Regime 2.01ฮฒ ยท 135% Vol 1.31ฮฒ ยท 58% Vol Lower Realized Risk GPCR
Unified Institutional Score Composite Signal 42.9 / 100 (HOLD) 40.9 / 100 (SELL) Higher Composite CELU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CELU vs GPCR Buy Guide
CELU BREAKDOWN
60d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CELU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GPCR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live GPCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CELU nor GPCR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.